Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Alternate-day micafungin antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic study.

Mehta PA, Vinks AA, Filipovich A, Bleesing J, Jodele S, Jordan MB, Marsh R, Tarin R, Edwards S, Fearing D, Lawrence J, Davies SM.

Biol Blood Marrow Transplant. 2010 Oct;16(10):1458-62. doi: 10.1016/j.bbmt.2010.05.002. Epub 2010 Jun 20. Erratum in: Biol Blood Marrow Transplant. 2011 Mar;17(3):441.

2.

[Is micafungin useful in the prophylaxis of invasive fungal disease in hematological patients?].

Salavert M, Jarque I.

Enferm Infecc Microbiol Clin. 2011 Mar;29 Suppl 2:43-9. doi: 10.1016/S0213-005X(11)70009-X. Review. Spanish.

PMID:
21420577
3.

[Why might micafungin be the drug of choice in pediatric patients?].

Ramos Amador JT, Prieto Tato L, Guillén Martín S.

Enferm Infecc Microbiol Clin. 2011 Mar;29 Suppl 2:23-8. doi: 10.1016/S0213-005X(11)70005-2. Review. Spanish.

PMID:
21420573
4.

Micafungin: a review of its use in the prophylaxis and treatment of invasive Candida infections in pediatric patients.

Carter NJ, Keating GM.

Paediatr Drugs. 2009;11(4):271-91. doi: 10.2165/00148581-200911040-00006. Review.

PMID:
19566111
5.

[Future role of micafungin in the treatment of invasive mycoses caused by filamentous fungi].

Salavert-Lletí M, Zaragoza-Crespo R.

Rev Iberoam Micol. 2009 Mar 31;26(1):81-9. doi: 10.1016/S1130-1406(09)70015-4. Epub 2009 May 7. Review. Spanish.

6.

Micafungin use in children.

Emiroglu M.

Expert Rev Anti Infect Ther. 2011 Sep;9(9):821-34. doi: 10.1586/eri.11.91. Review.

PMID:
21905789
8.

[Differential pharmacokinetic characteristics of micafungin. Experience in special populations].

Grau Cerrato S, Luque Pardos S, Ferrández Quirante O.

Enferm Infecc Microbiol Clin. 2011 Mar;29 Suppl 2:10-4. doi: 10.1016/S0213-005X(11)70003-9. Review. Spanish.

PMID:
21420571
9.

Micafungin: a brief review of pharmacology, safety, and antifungal efficacy in pediatric patients.

Lehrnbecher T, Groll AH.

Pediatr Blood Cancer. 2010 Aug;55(2):229-32. doi: 10.1002/pbc.22449. Review.

PMID:
20583216
10.

[Pharmacodynamics and pharmacokinetics of micafungin in adults, children and neonate].

Catalán-González M, Carlos Montejo-González J.

Rev Iberoam Micol. 2009 Mar 31;26(1):23-34. doi: 10.1016/S1130-1406(09)70005-1. Epub 2009 May 7. Review. Spanish. Erratum in: Rev Iberoam Micol. 2009 Jun 30;26(2):166..

11.

[Micafungin in invasive candidiasis among oncohematological patients].

Jarque I, Angel Sanz M.

Rev Iberoam Micol. 2009 Mar 31;26(1):75-7. doi: 10.1016/S1130-1406(09)70013-0. Epub 2009 May 7. Review. Spanish.

12.

[Scientific evidence supporting the use of micafungin in the treatment of invasive candidiasis].

Montejo M, Quindós G.

Enferm Infecc Microbiol Clin. 2011 Mar;29 Suppl 2:15-22. doi: 10.1016/S0213-005X(11)70004-0. Review. Spanish.

PMID:
21420572
13.

Single or 2-Dose Micafungin Regimen for Treatment of Invasive Candidiasis: Therapia Sterilisans Magna!

Gumbo T.

Clin Infect Dis. 2015 Dec 1;61 Suppl 6:S635-42. doi: 10.1093/cid/civ715. Review.

PMID:
26567282
14.

Safety of micafungin in infants: insights into optimal dosing.

Ascher S, Smith PB, Benjamin DK Jr.

Expert Opin Drug Saf. 2011 Mar;10(2):281-6. doi: 10.1517/14740338.2011.545345. Epub 2011 Jan 13. Review.

15.

Echinocandin use in the neonatal intensive care unit.

Caudle KE, Inger AG, Butler DR, Rogers PD.

Ann Pharmacother. 2012 Jan;46(1):108-16. doi: 10.1345/aph.1Q346. Epub 2011 Dec 20. Review.

PMID:
22190252
16.

[Micafungin for therapy of invasive candidiasis in solid organ transplant recipients].

Fortún-Abete J.

Rev Iberoam Micol. 2009 Mar 31;26(1):65-8. doi: 10.1016/S1130-1406(09)70011-7. Epub 2009 May 7. Review. Spanish.

17.

[Drug interactions in critically-ill patients. An important factor in the use of micafungin?].

Garnacho-Montero J, Jiménez Parrilla F.

Enferm Infecc Microbiol Clin. 2011 Mar;29 Suppl 2:33-7. doi: 10.1016/S0213-005X(11)70007-6. Review. Spanish.

PMID:
21420575
18.

[Micafungin in pediatric and adolescent patients].

Madero-López L.

Rev Iberoam Micol. 2009 Mar 31;26(1):62-4. doi: 10.1016/S1130-1406(09)70010-5. Epub 2009 May 7. Review. Spanish.

19.

Efficacy and safety of echinocandins versus triazoles for the prophylaxis and treatment of fungal infections: a meta-analysis of RCTs.

Wang JF, Xue Y, Zhu XB, Fan H.

Eur J Clin Microbiol Infect Dis. 2015 Apr;34(4):651-9. doi: 10.1007/s10096-014-2287-4. Epub 2014 Dec 14. Review.

20.

[Antifungal therapy update: new drugs and medical uses].

Fortún J.

Enferm Infecc Microbiol Clin. 2011 Dec;29 Suppl 5:38-44. doi: 10.1016/S0213-005X(11)70042-8. Review. Spanish.

PMID:
22305668

Supplemental Content

Support Center